Clinical Trial Update: Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing myo-inositol for embryo development in women with Polycystic Ovary Syndrome undergoing ICSI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Polycystic Ovary Syndrome

Drugs mentioned

• Myo-inositol (myo-inositol)

Snippet

Sponsor: Medical University of Lublin | Conditions: Polycystic Ovary Syndrome, Infertility | Phase 2 | Status: COMPLETED